{"id":393716,"date":"2020-12-04T16:08:25","date_gmt":"2020-12-04T21:08:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=393716"},"modified":"2020-12-04T16:08:25","modified_gmt":"2020-12-04T21:08:25","slug":"stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","title":{"rendered":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference"},"content":{"rendered":"

<\/p>\n

Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference<\/b><\/p>\n

BEDFORD, Mass.–(BUSINESS WIRE<\/a>)–
\nStoke Therapeutics, Inc., (Nasdaq: STOK), a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Needham Virtual Epilepsy & Pain \u2013 Specialty Therapeutics Conference on Thursday, December 10, 2020, at 12:45 p.m. ET.\n<\/p>\n

\nA live audio webcast of the fireside chat will be available on the Investors & Media section of Stoke\u2019s website at https:\/\/investor.stoketherapeutics.com\/<\/a>. A replay of the webcast will be available for 30 days following the presentations.\n<\/p>\n

About Stoke Therapeutics<\/b><\/p>\n

\nStoke Therapeutics (Nasdaq: STOK), is a clinical-stage biotechnology company pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50% of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts. For more information, visit https:\/\/www.stoketherapeutics.com\/<\/a> or follow the company on Twitter at @StokeTx<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201204005555\/en\/<\/a><\/span><\/p>\n

Stoke Media & Investor Contact:
\n<\/b>
Dawn Kalmar
\n
Vice President, Head of Corporate Affairs
\n
dkalmar@stoketherapeutics.com
\n<\/a>
781-303-8302\n<\/p>\n

KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Genetics Other Health General Health Clinical Trials Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference BEDFORD, Mass.–(BUSINESS WIRE)– Stoke Therapeutics, Inc., (Nasdaq: STOK), a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Needham Virtual Epilepsy & Pain \u2013 Specialty Therapeutics Conference on Thursday, December 10, 2020, at 12:45 p.m. ET. A live audio webcast of the fireside chat will be available on the Investors & Media section of Stoke\u2019s website at https:\/\/investor.stoketherapeutics.com\/. A replay of the webcast will be available for 30 days following the presentations. About Stoke Therapeutics … <\/p>\n

Continue reading “Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-393716","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nStoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference BEDFORD, Mass.–(BUSINESS WIRE)– Stoke Therapeutics, Inc., (Nasdaq: STOK), a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Needham Virtual Epilepsy & Pain \u2013 Specialty Therapeutics Conference on Thursday, December 10, 2020, at 12:45 p.m. ET. A live audio webcast of the fireside chat will be available on the Investors & Media section of Stoke\u2019s website at https:\/\/investor.stoketherapeutics.com\/. A replay of the webcast will be available for 30 days following the presentations. About Stoke Therapeutics … Continue reading "Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-04T21:08:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference\",\"datePublished\":\"2020-12-04T21:08:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"},\"wordCount\":314,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\",\"name\":\"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-04T21:08:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","og_locale":"en_US","og_type":"article","og_title":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","og_description":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference BEDFORD, Mass.–(BUSINESS WIRE)– Stoke Therapeutics, Inc., (Nasdaq: STOK), a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will participate in a fireside chat at the Needham Virtual Epilepsy & Pain \u2013 Specialty Therapeutics Conference on Thursday, December 10, 2020, at 12:45 p.m. ET. A live audio webcast of the fireside chat will be available on the Investors & Media section of Stoke\u2019s website at https:\/\/investor.stoketherapeutics.com\/. A replay of the webcast will be available for 30 days following the presentations. About Stoke Therapeutics … Continue reading \"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-04T21:08:25+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference","datePublished":"2020-12-04T21:08:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"},"wordCount":314,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/","name":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-04T21:08:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201204005555r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stoke-therapeutics-to-present-at-the-needham-virtual-epilepsy-pain-specialty-cns-therapeutics-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Stoke Therapeutics to Present at the Needham Virtual Epilepsy & Pain \u2013 Specialty CNS Therapeutics Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=393716"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393716\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=393716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=393716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=393716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}